> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Review Biogen Alzheimer’s BLA
- URL: https://www.fdaweb.com/panel-to-review-biogen-alzheimers-bla/
- Published: 2020-09-28T12:00:00.000Z
- Updated: 2026-09-14T16:30:30.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5147743

*Federal Register* notice: FDA has announced an 11/6 Peripheral and Central Nervous System Drugs Advisory Committee. Panel members are scheduled to review a Biogen BLA for aducanumab solution for intravenous infusion for treating Alzheimer’s disease. To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2020-21448.pdf?ref=fdaweb.com).